TY - STD TI - World Health Organization.http://www.who.int/mediacentre/factsheets/fs312/en/index.html, UR - http://www.who.int/mediacentre/factsheets/fs312/en/index.html ID - ref1 ER - TY - STD TI - The Danish Diabetes Association.http://www.diabetes.dk/Rundt_om_diabetes/Type_2_diabetes.aspx, UR - http://www.diabetes.dk/Rundt_om_diabetes/Type_2_diabetes.aspx ID - ref2 ER - TY - JOUR PY - 1998 DA - 1998// TI - Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) JO - Lancet VL - 352 UR - https://doi.org/10.1016/S0140-6736(98)07019-6 DO - 10.1016/S0140-6736(98)07019-6 ID - ref3 ER - TY - JOUR AU - Mudaliar, S. AU - Edelman, S. V. PY - 2001 DA - 2001// TI - Insulin therapy in type 2 diabetes JO - Endocrinol Metab Clin North Am VL - 30 UR - https://doi.org/10.1016/S0889-8529(05)70222-X DO - 10.1016/S0889-8529(05)70222-X ID - Mudaliar2001 ER - TY - JOUR AU - Meneghini, L. PY - 2008 DA - 2008// TI - Demonstrating strategies for initiation of insulin therapy: matching the right insulin to the right patient JO - Int J Clin Pract VL - 62 UR - https://doi.org/10.1111/j.1742-1241.2008.01816.x DO - 10.1111/j.1742-1241.2008.01816.x ID - Meneghini2008 ER - TY - JOUR AU - Bullano, M. F. AU - Al-Zakwani, I. S. AU - Fisher, M. D. AU - Menditto, L. AU - Willey, V. J. PY - 2005 DA - 2005// TI - Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products JO - Curr Med Res Opin VL - 21 UR - https://doi.org/10.1185/030079905X26234 DO - 10.1185/030079905X26234 ID - Bullano2005 ER - TY - JOUR AU - Heise, T. AU - Pieber, T. R. PY - 2007 DA - 2007// TI - Towards peakless, reproducible and long-acting insulins JO - An assessment of the basal analogues based on isoglycaemic clamp studies. Diabetes Obes Metab VL - 9 ID - Heise2007 ER - TY - JOUR AU - Hermansen, K. AU - Madsbad, S. AU - Perrild, H. AU - Kristensen, A. AU - Axelsen, M. PY - 2001 DA - 2001// TI - Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy JO - Diabetes Care VL - 24 UR - https://doi.org/10.2337/diacare.24.2.296 DO - 10.2337/diacare.24.2.296 ID - Hermansen2001 ER - TY - JOUR AU - Hermansen, K. AU - Davies, M. AU - Derezinski, T. AU - Martinez, R. G. AU - Clauson, P. AU - Home, P. PY - 2006 DA - 2006// TI - A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes JO - Diabetes Care VL - 29 UR - https://doi.org/10.2337/dc05-1365 DO - 10.2337/dc05-1365 ID - Hermansen2006 ER - TY - JOUR AU - Philis-Tsimikas, A. AU - Charpentier, G. AU - Clauson, P. AU - Ravn, G. M. AU - Roberts, V. L. AU - Thorsteinsson, B. PY - 2006 DA - 2006// TI - Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes JO - Clin Ther VL - 28 UR - https://doi.org/10.1016/j.clinthera.2006.10.020 DO - 10.1016/j.clinthera.2006.10.020 ID - Philis-Tsimikas2006 ER - TY - JOUR AU - Philis-Tsimikas, A. PY - 2008 DA - 2008// TI - An update on the use of insulin detemir, with a focus on type 2 diabetes (drug evaluation update) JO - Expert Opin Pharmacother VL - 9 UR - https://doi.org/10.1517/14656566.9.12.2181 DO - 10.1517/14656566.9.12.2181 ID - Philis-Tsimikas2008 ER - TY - JOUR AU - Hollander, P. AU - Cooper, J. AU - Bregnhoj, J. AU - Pedersen, C. B. PY - 2008 DA - 2008// TI - A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes JO - Clin Ther VL - 30 UR - https://doi.org/10.1016/j.clinthera.2008.11.001 DO - 10.1016/j.clinthera.2008.11.001 ID - Hollander2008 ER - TY - JOUR AU - Monami, M. AU - Marchionni, N. AU - Mannucci, E. PY - 2008 DA - 2008// TI - Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis JO - Diabetes Res Clin Pract VL - 81 UR - https://doi.org/10.1016/j.diabres.2008.04.007 DO - 10.1016/j.diabres.2008.04.007 ID - Monami2008 ER - TY - JOUR AU - Raskin, P. AU - Gylvin, T. AU - Weng, W. AU - Chaykin, L. PY - 2009 DA - 2009// TI - Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes JO - Diabetes Metab Res Rev VL - 25 UR - https://doi.org/10.1002/dmrr.989 DO - 10.1002/dmrr.989 ID - Raskin2009 ER - TY - JOUR AU - Rosenstock, J. AU - Davies, M. AU - Home, P. D. AU - Larsen, J. AU - Koenen, C. AU - Schernthaner, G. PY - 2008 DA - 2008// TI - A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes JO - Diabetologia VL - 51 UR - https://doi.org/10.1007/s00125-007-0911-x DO - 10.1007/s00125-007-0911-x ID - Rosenstock2008 ER - TY - JOUR AU - Dornhorst, A. AU - Luddeke, H. J. AU - Koenen, C. AU - Merilainen, M. AU - King, A. AU - Robinson, A. PY - 2008 DA - 2008// TI - Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data from PREDICTIVE JO - Diabetes Obes Metab VL - 10 ID - Dornhorst2008 ER - TY - JOUR AU - Meneghini, L. F. AU - Rosenberg, K. H. AU - Koenen, C. AU - Merilainen, M. J. AU - Luddeke, H. J. PY - 2007 DA - 2007// TI - Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study JO - Diabetes Obes Metab VL - 9 UR - https://doi.org/10.1111/j.1463-1326.2006.00674.x DO - 10.1111/j.1463-1326.2006.00674.x ID - Meneghini2007 ER - TY - JOUR AU - Fakhoury, W. AU - Lockhart, I. AU - Kotchie, R. W. AU - Aagren, M. AU - Lereun, C. PY - 2008 DA - 2008// TI - Indirect comparison of once daily insulin detemir and glargine in reducing weight gain and hypoglycaemic episodes when administered in addition to conventional oral anti-diabetic therapy in patients with type-2 diabetes JO - Pharmacology VL - 82 UR - https://doi.org/10.1159/000149569 DO - 10.1159/000149569 ID - Fakhoury2008 ER - TY - JOUR AU - Borah, B. J. AU - Darkow, T. AU - Bouchard, J. AU - Aagren, M. AU - Forma, F. AU - Alemayehu, B. PY - 2009 DA - 2009// TI - A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes JO - Clin Ther VL - 31 UR - https://doi.org/10.1016/j.clinthera.2009.03.005 DO - 10.1016/j.clinthera.2009.03.005 ID - Borah2009 ER - TY - JOUR AU - McAdam-Marx, C. AU - Yu, J. AU - Bouchard, J. AU - Aagren, M. AU - Brixner, D. I. PY - 2010 DA - 2010// TI - Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin JO - Curr Med Res Opin VL - 26 UR - https://doi.org/10.1185/03007990903432470 DO - 10.1185/03007990903432470 ID - McAdam-Marx2010 ER - TY - JOUR AU - Heintjes, E. M. AU - Thomsen, T. L. AU - Penning-van Beest, F. J. AU - Christensen, T. E. AU - Herings, R. M. PY - 2010 DA - 2010// TI - Glycemic control and long-acting insulin analog utilization in patients with type 2 diabetes JO - Adv Ther VL - 27 UR - https://doi.org/10.1007/s12325-010-0020-y DO - 10.1007/s12325-010-0020-y ID - Heintjes2010 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6823/12/21/prepub UR - http://www.biomedcentral.com/1472-6823/12/21/prepub ID - ref22 ER -